|
MechanismPDE5A inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Australia |
First Approval Date23 Oct 2002 |
|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Canada |
First Approval Date01 Jan 1985 |
100 Clinical Results associated with Beijing Quantum Hi Tech Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Beijing Quantum Hi Tech Pharmaceutical Technology Co., Ltd.
100 Deals associated with Beijing Quantum Hi Tech Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Beijing Quantum Hi Tech Pharmaceutical Technology Co., Ltd.